This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Narimatsu, H. Articles by Hirohashi, S. Search for Related Content PubMed PubMed Citation Articles by Narimatsu, H. Articles by Hirohashi, S.

Genetic Evidence for the Lewis Enzyme, Which Synthesizes Type-1 Lewis Antigens in Colon Tissue, and Intracellular Localization of the Enzyme¹

Division of Cell Biology, Institute of Life Science, Soka University, 1-236 Tangicho, Hachioji, Tokyo 192 [H. N., H. I., S. N., H. K., T. K.]; Pathology Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104 [Y. Y., S. H.]; and Department of Microbiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160 [T. K.], Japan

To determine whether the Lewis enzyme responsible for the Lewis blood type antigens on erythrocytes synthesizes the Lewis antigens on normal cells and cancer cells in colon tissue, we performed genotyping of the Lewis gene by the PCR-RFLP method and by immunohistochemical staining of Lewis antigens and the Lewis enzyme with specific monoclonal antibodies (mAbs) in colon tissue obtained from 100 colon cancer patients. Five of the 100 patients were identified as homozygotes for the mutant Lewis gene, i.e., the le/le genotype that cannot encode functional Lewis enzyme. The cells in both the normal and cancerous regions of colon tissue from these five le/le patients were completely devoid of staining with mAbs against Lewis antigens with the type 1 chain, i.e., Lewis a, Lewis b, and sialyl Lewis a. In contrast, the cells in cancerous regions of the colon tissue of the 95 patients with the Le/Le or Le/le genotype positively stained with all three mAbs, anti-Lewis a, anti-Lewis b, and anti-sialyl Lewis a. The cells in the cancerous regions of the colon tissue of the five le/le patients stained with DU-PAN-2 mAb, whose recognizing epitope is known to be sialyl Lewis c, a precursor structure of sialyl Lewis a. By immunohistochemical staining with FTA 1–16 mAb, which is directed at the human Lewis enzyme, we were able to demonstrate for the first time that the enzyme is localized in the Golgi area of the colon epithelial cells of patients with the Le/Le or Le/le genotype. No staining was observed in the Golgi area of the cells of the patients with the le/le genotype. From these results, we conclude that individuals with the Le/Le or Le/le genotype possess a functional Lewis enzyme synthesizing fucosylated type-1 Lewis antigens in the Golgi apparatus of the colon epithelial cells, but that individuals with the le/le genotype are devoid of the Lewis enzyme in the Golgi apparatus, resulting in an inability to synthesize Lewis antigens with the type-1 chain, and that it is inappropriate to use CA19-9, whose antigenic epitope is defined as sialyl Lewis a, as a tumor marker in patients with the le/le genotype.

¹ Supported in part by a Grant-in-Aid for Scientific Research on Priority Areas No. 05274103 from the Ministry of Education, Science, and Culture, Japan.

² To whom requests for reprints should be addressed, at Division of Cell Biology, Institute of Life Science, Soka University, 1-236 Tangicho, Hachioji, Tokyo 192, Japan. Phone: 81-426-91-9466 or 81-426-91-9470; Fax: 81-426-91-9315; E-mail: hisashi@t.soka.ac.jp.

Received 8/22/95. Accepted 11/ 8/95.

This article has been cited by other articles:

				E. G. Berger Ectopic localizations of Golgi glycosyltransferases Glycobiology, February 1, 2002; 12(2): 29R - 36R. [Abstract] [Full Text] [PDF]

				Y. Ikehara, S. Nishihara, H. Yasutomi, T. Kitamura, K. Matsuo, N. Shimizu, K.-i. Inada, Y. Kodera, Y. Yamamura, H. Narimatsu, et al. Polymorphisms of Two Fucosyltransferase Genes (Lewis and Secretor Genes) Involving Type I Lewis Antigens Are Associated with the Presence of Anti-Helicobacter pylori IgG Antibody Cancer Epidemiol. Biomarkers Prev., September 1, 2001; 10(9): 971 - 977. [Abstract] [Full Text] [PDF]

				H. Kanazawa, M. Ebina, N. Ino-oka, M. Shimizukawa, T. Takahashi, S. Fujimura, T. Imai, and T. Nukiwa Transition from Squamous Cell Carcinoma to Adenocarcinoma in Adenosquamous Carcinoma of the Lung Am. J. Pathol., April 1, 2000; 156(4): 1289 - 1298. [Abstract] [Full Text] [PDF]

				S. Isshiki, A. Togayachi, T. Kudo, S. Nishihara, M. Watanabe, T. Kubota, M. Kitajima, N. Shiraishi, K. Sasaki, T. Andoh, et al. Cloning, Expression, and Characterization of a Novel UDP-galactose:beta -N-Acetylglucosamine beta 1,3-Galactosyltransferase (beta 3Gal-T5) Responsible for Synthesis of Type 1 Chain in Colorectal and Pancreatic Epithelia and Tumor Cells Derived Therefrom J. Biol. Chem., April 30, 1999; 274(18): 12499 - 12507. [Abstract] [Full Text] [PDF]

				T. Kudo, Y. Ikehara, A. Togayachi, M. Kaneko, T. Hiraga, K. Sasaki, and H. Narimatsu Expression Cloning and Characterization of a Novel Murine alpha 1,3-Fucosyltransferase, mFuc-TIX, That Synthesizes the Lewis x (CD15) Epitope in Brain and Kidney J. Biol. Chem., October 9, 1998; 273(41): 26729 - 26738. [Abstract] [Full Text] [PDF]

				M. Kaneko, S. Nishihara, N. Shinya, T. Kudo, H. Iwasaki, T. Seno, Y. Okubo, and H. Narimatsu Wide Variety of Point Mutations in the H Gene of Bombay and Para-Bombay Individuals That Inactivate H Enzyme Blood, July 15, 1997; 90(2): 839 - 849. [Abstract] [Full Text] [PDF]